Diteba will operate as a wholly owned subsidiary of NDI under the corporate name of NDI ADRL Inc. to provide ingredient, product and bioanalytical services in the areas of method development, validation and routine testing services associated with NDI’s Product Analytics, Human Diagnostics, Pharmaceutical Drug Development and Dietary Supplement Clinical Trials divisions.
Diteba will continue to offer its advanced bioanalytical methods to its existing customers in the biotechnology sector.
NDI will maintain its established and accredited network of suppliers of innovative analytical chemistry procedures.